Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Mifepristone taj API

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Mifepristone Manufacturers in India Suppliers Mifepristone Exporters Distributors Mifepristone api active pharmaceuticals ingredients Mifepristone manufacturers Side Effects bulk drugs raw material Mifepristone companies Side Effects Importers Mifepristone Mifepristone Exporters Mifepristone exporters FDA Mifepristone DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Mifepristone manufacturing pharmaceutical drugs pharmaceutical intermediates Mifepristone pharmaceutical chemicals pharmaceutical raw materials Mifepristone active pharmaceutical ingredients Mifepristone committee active pharmaceutical ingredients manufacturer Mifepristone Active Pharmaceutical Ingredients manufacturer Mifepristone exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Mifepristone, Mifepristone manufacturer India, Mifepristone product, Mifepristone products, Api preparation, Certificate of Analysis API manufacturer product, Mifepristone anti ulcer product, Certificate of Origin COA Mifepristone COS Mifepristone, pharmaceutical generic, pharmaceutical drug, medical, Mifepristone pharma healthcare, pharma patents, contract MSDS manufacturing Trader Mifepristone pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Mifepristone expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Mifepristone DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Mifepristone ingredients, api, HIV Mifepristone, tablets, capsules, syrup & protein Mifepristone powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Mifepristone gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Mifepristone WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

Chemical Taj Pharmaceuticals Ltd.










 




 








 

 

HOME >> API >> API List 2 >> Mifepristone >> Precautions

Mifepristone

PRECAUTIONS
Mifepristone CAS Number 84371-65-3

Each patient must understand:

* the necessity of completing the treatment schedule, including a follow-up visit approximately 14 days after taking Mifeprex;
* that vaginal bleeding and uterine cramping probably will occur;
* that prolonged heavy vaginal bleeding is not proof of a complete abortion;
* that if the treatment fails, there is a risk of fetal malformation;
* that medical abortion treatment failures are managed by surgical termination; and
* the steps to take in an emergency situation, including precise instructions and a telephone number that she can call if she has any problems or concerns.

Another pregnancy can occur following termination of pregnancy and before resumption of normal menses. Contraception can be initiated as soon as the termination of the pregnancy has been confirmed, or before the woman resumes sexual intercourse.

This medication should not be used if you have certain medical conditions or other problems. Before using this medicine, consult your doctor if you have any of the following: undiagnosed abdominal growth (adnexal mass), certain adrenal gland problem (chronic adrenal failure), bleeding problem (e.g., coagulopathy), certain blood disorder (inherited porphyrias), IUD (intrauterine birth control device) in place, pregnancy longer than 7 weeks, proven or possible abnormal pregnancy outside the womb (ectopic pregnancy), unable to return for a doctor's visit in 48 hours and again in 14 days, unable to easily get emergency help in the 2 weeks after taking mifepristone.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS
PRECAUTIONS >>
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Mifepristone

Api Manufacturer,Export,Supplies,Manufacturing

Gabapentin

Gemcitabine Hcl

Glimepiride

Granisetron Hcl

Ibandronate Sodium

Imatinib Mesylate

Irbesartan

Irinotecan Hcl

Isradipine

Lamotrigine

Lercanidipine

Letrozole

Losartan Potassium

Loteprednol Etabonate

Magnesium Valproate

Meloxicam

Memantine Hcl

Mesalazine

Metamizol Magnesium

Metaxalone

Metformin Hcl

Metoprolol Tartrate

Mifepristone

Mirtazapine

Modafinil

Mometasone Furoate

Naltrexone Hcl

Netaglinide

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.